Edition:
India

Nate Raymond

IN BRIEF: Ohio doctor accused of accepting Insys kickbacks expects indictment

24 Aug 2019

Federal prosecutors are planning to charge an Ohio doctor accused of writing hundreds of opioid prescriptions that lacked a legitimate medical purpose and accepting kickbacks from drugmaker Insys Therapeutics Inc, his lawyers said on Friday.

Stallergenes Greer defeats whistleblower lawsuit over allergenic extract blends

24 Aug 2019

Allergy treatment manufacturer Stallergenes Greer has won the dismissal of a whistleblower lawsuit accusing the company of selling unlicensed custom blends of allergenic extracts to doctors that were then billed to government healthcare programs.

3rd Circuit to reconsider if Amazon is 'seller' of third-party products

24 Aug 2019

A federal appeals court on Friday agreed to reconsider a ruling that would allow customers in Pennsylvania to hold Amazon.com Inc liable as the seller of defective products sold by third-parties through its online marketplace.

EXPLAINER: Oklahoma judge weighs if J&J created opioid public nuisance

23 Aug 2019

A lawsuit by Oklahoma's attorney general accusing Johnson & Johnson of fueling the opioid epidemic is set to establish a major precedent over whether a state's public nuisance laws can be used to hold a drugmaker liable for the U.S. drug crisis.

Concerns about Insys employee wrongdoing justify new severance plan, says judge

23 Aug 2019

A federal bankruptcy judge on Thursday instructed Insys Therapeutics Inc to come up with a new severance program after creditors demanded assurances that no employees involved in criminal wrongdoing at the opioid manufacturer would get paid.

Philip Morris loses appeal in lawsuit over Connecticut smoker's death

23 Aug 2019

A federal appeals court on Thursday ruled a judge misapplied the law in barring a man who claimed Philip Morris USA's cigarettes caused his wife's lung cancer death to rely at trial on facts derived from the U.S. government's own tobacco litigation.

Oklahoma judge to rule on Monday in opioid lawsuit against J&J

22 Aug 2019

An Oklahoma judge will rule on Monday on whether Johnson & Johnson should be held liable in a lawsuit by the state's attorney general who argues the drugmaker should be forced to pay $17 billion for fueling the opioid epidemic.

Conrail ducks brakeman's whistleblower retaliation case on appeal

22 Aug 2019

A requirement that railroad workers file a complaint with the U.S. Occupational Safety and Health Administration within 180 days of a carrier engaging in whistleblower retaliation is not a rule that strips courts of jurisdiction over such cases, a federal appeals court ruled on Wednesday.

Judge won't certify class in Intuniv 'pay-for-delay' lawsuit

22 Aug 2019

A federal judge on Wednesday declined to certify a class of consumers alleging Shire PLC entered into an improper deal to delay the release of a generic, cheaper version of the ADHD drug Intuniv, finding many consumers were uninjured by its actions.

Insys creditors want assurance no severance goes to 'complicit' employees

22 Aug 2019

Insys Therapeutics Inc's unsecured creditors and five states want the drugmaker to ensure no employees "complicit in bad acts" receive severance after several executives were convicted of paying doctors bribes to prescribe an opioid medication.

World News